NEW YORK, April 3, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding
Methanex Corp. (NASDAQ: MEOH), W.R.
Grace & Co. (NYSE: GRA), Chemtura Corporation (NYSE:
CHMT), NewMarket Corp. (NYSE: NEU), and HB Fuller Co. (NYSE: FUL).
Private wealth members receive these notes ahead of publication. To
reserve complementary membership, limited openings are available
at: http://www.AnalystsReview.com/register
--
Methanex Corp. Analyst Notes
On the corporate website of Methanex Corp. (Methanex), the
Company posted the schedule for its upcoming Q1 2014 financial
results. The quarterly earnings will be released on April 29, 2014, Tuesday. In conjunction with its
earnings release, the Company will also host a conference call to
discuss the results on April 30,
2014, Wednesday, at 9:00 a.m.
PT/12:00 p.m. ET. The full
analyst notes on Methanex Corp. are available to download free of
charge at:
http://www.AnalystsReview.com/04032014/MEOH/report.pdf
--
W.R. Grace & Co. Analyst
Notes
On March 31, 2014, W.R. Grace & Co.'s (Grace) stock rose 0.50%
to end the day at $99.17, compared to
its previous day closing price of $98.68. The Company's stock grew 13.47% over the
past six trading months. In comparison, the broader market indices
- Dow Jones Industrial Average and S&P 500 rose 8.77% and
11.34%, respectively, during the same trading period. The full
analyst notes on W.R. Grace &
Co. are available to download free of charge at:
http://www.AnalystsReview.com/04032014/GRA/report.pdf
--
Chemtura Corporation Analyst Notes
On March 24, 2014, Chemtura Corp.
(Chemtura) announced the schedule of its quarterly earnings
release. The Company intends to release its Q1 2014 financial
results as well as file its Form 10-Q on April 30, 2014, Wednesday, after the market
close. The Company will hold a conference call to discuss these
results on the following day, May 1,
2014, Thursday, at 9:00 a.m.
EDT. Chemtura informed that a webcast of the teleconference
will be available on the Investor Relations section of its website.
The full analyst notes on Chemtura Corporation are available to
download free of charge at:
http://www.AnalystsReview.com/04032014/CHMT/report.pdf
--
NewMarket Corp. Analyst Notes
On March 31, 2014, NewMarket
Corp.'s (NewMarket) stock increased 1.91% to end the day at
$390.78, compared to its previous day
closing price of $383.46. In the last
one month, the Company's stock grew 5.62%, beating the Dow Jones
Industrial Average which rose 1.13%, and the S&P 500 which grew
0.97% during the same trading period. The full analyst notes on
NewMarket Corp. are available to download free of charge at:
http://www.AnalystsReview.com/04032014/NEU/report.pdf
--
HB Fuller Co. Analyst Notes
On March 26, 2014, H.B. Fuller Co.
(H.B. Fuller) reported its Q1 FY
2014 financial results (period ended March
1, 2014). For the quarter, the Company reported net revenue
of $486.0 million, up 1.3% YoY. Net
income attributable to H.B. Fuller
came in at $14.6 million,
$0.28 per diluted share, compared to
$20.7 million, or $0.41 per diluted share, in Q1 FY 2013. Adjusted
diluted EPS was $0.49, which remained
unchanged from Q1 FY 2013. Jim
Owens, H.B. Fuller President
and CEO said, "During the first quarter, we hit a number of key
milestones on our transformation programs and we remain on track
toward hitting our goal of 15 percent EBITDA margin in 2015, while
still delivering the expected level of EPS during this quarter."
The full analyst notes on HB Fuller Co. are available to download
free of charge at:
http://www.AnalystsReview.com/04032014/FUL/report.pdf
--
About Analysts Review
We provide our members with a simple and reliable way to leverage
our economy of scale. Most investors do not have time to track all
publicly traded companies, much less perform an in-depth review and
analysis of the complexities contained in each situation. That's
where Analysts Review comes in. We provide a single unified
platform for investors' to hear about what matters. Situation
alerts, moving events, and upcoming opportunities.
--
=============
EDITOR NOTES:
- This is not company news. We are an independent source and our
views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a
best efforts basis and reviewed by Nidhi Vatsal, a CFA
charterholder. However, we are only human and are prone to make
mistakes. If you notice any errors or omissions, please notify us
below.
- This information is submitted as a net-positive to companies
mentioned, to increase awareness for mentioned companies to our
subscriber base and the investing public.
- If you wish to have your company covered in more detail by our
team, or wish to learn more about our services, please contact us
at pubco [at] AnalystsReview.com.
- For any urgent concerns or inquiries, please contact us
at compliance [at] AnalystsReview.com.
- Are you a public company? Would you like to see similar
coverage on your company? Send us a full investors' package to
research [at] AnalystsReview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort
basis. This document, article or report is prepared and authored by
Analysts Review. An outsourced research services provider
represented by Nidhi Vatsal, CFA, has only reviewed the information
provided by Analysts Review in this article or report according to
the Procedures outlined by Analysts Review. Analysts Review is not
entitled to veto or interfere in the application of such procedures
by the outsourced provider to the articles, documents or reports,
as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to
the accuracy or completeness or fitness for a purpose (investment
or otherwise), of the information provided in this document. This
information is not to be construed as personal financial advice.
Readers are encouraged to consult their personal financial advisor
before making any decisions to buy, sell or hold any securities
mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be
occasioned at the time of printing of this document or any error,
mistake or shortcoming. No liability is accepted by Analysts Review
whatsoever for any direct, indirect or consequential loss arising
from the use of this document. Analysts Review expressly disclaims
any fiduciary responsibility or liability for any consequences,
financial or otherwise arising from any reliance placed on the
information in this document. Analysts Review does not (1)
guarantee the accuracy, timeliness, completeness or correct
sequencing of the information, or (2) warrant any results from use
of the information. The included information is subject to change
without notice.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
AnalystsReview.com
SOURCE Analysts Review